ERBB2 and breast carcinoma: In breast cancer cell lines that overexpress HER-2 (BT-474 and SK-BR-3-h), curcumin downregulated the HER-2 oncoprotein and also the phosphorylation of MAPK in a dose-and time-dependent manner (Lai et al., 2012).